![](https://webarchive.library.unt.edu/eot2008/20090118170307im_/http://www.fda.gov/graphics/dot_clear.gif) |
Advisory
Committees
Nature and Basis Statements of Conflict(s)
of Interest for Voting Members of FDA Advisory Committee Members
The Agency is revising its procedures
regarding the disclosure of conflicts of interest and waivers for
voting advisory committee members in order to implement the requirements
of section 795 of Pub. L. No. 109-97 (Agriculture, Rural Development,
Food and Drug Administration, and Related Agencies Appropriations
Act, 2006) (Nov. 10, 2005). This information is being provided as
an interim measure to comply with the requirements of this law.
Circulatory System Devices Panel
December 7-8, 2006
Robert A. Harrington, M.D.
- 18 U.S.C. 208 waiver (pdf)
JoAnn Lindenfeld, M.D.
- 18 U.S.C. 208 waiver (pdf)
Richard L. Page, M.D.
- 18 U.S.C. 208 waiver (pdf)
George W. Vetrovec, M.D.
- 18 U.S.C. 208 waiver (pdf)
Judah Z. Weinberger, M.D., Ph.D.
On December 1st, Dr. Weinberger informed FDA that this financial interest no longer exists. As such, a waiver is not necessary to authorize his participation in the meeting. (Updated 12/4/2006)
- 18 U.S.C. 208 waiver (pdf)
Clyde W. Yancy, M.D.
- 18 U.S.C. 208 waiver (pdf)
Page updated:
December 4, 2006
|
![](https://webarchive.library.unt.edu/eot2008/20090118170307im_/http://www.fda.gov/graphics/dot_clear.gif) |